Jane Reese-Coulbourne. Interviewed by Asher Mullard.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Works matching IS 14741776 AND DT 2012 AND VI 11 AND IP 8
Results: 24
1
2
Metabolic disorders: New target for appetite control.
- Published in:
- 2012
- By:
- Publication type:
- journal article
3
Jane Reese-Coulbourne.
- Published in:
- 2012
- Publication type:
- Interview
4
G protein-coupled receptors for energy metabolites as new therapeutic targets.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 603, doi. 10.1038/nrd3777
- By:
- Publication type:
- Article
5
Autoimmune disease: Targeting IL-7 reverses type 1 diabetes.
- Published in:
- 2012
- By:
- Publication type:
- journal article
6
DSM-5 and clinical trials in psychiatry: challenges to come?
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 583, doi. 10.1038/nrd3811
- By:
- Publication type:
- Article
7
Anticancer drugs: Synthetic lethality enables targeting of MYC.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 602, doi. 10.1038/nrd3816
- By:
- Publication type:
- Article
8
Neurodegenerative disorders: Reversing Huntington's disease.
- Published in:
- 2012
- By:
- Publication type:
- journal article
9
Adverse drug reactions: Computational model predicts side effects.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 602, doi. 10.1038/nrd3813
- By:
- Publication type:
- Article
10
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 589, doi. 10.1038/nrd3821
- Publication type:
- Article
11
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 592, doi. 10.1038/nrd3820
- By:
- Publication type:
- Article
12
Psychiatric disorders: Targeting a PI3K subunit in schizophrenia.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 602, doi. 10.1038/nrd3814
- By:
- Publication type:
- Article
13
A new dawn in the sleep disorders pipeline?
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 595, doi. 10.1038/nrd3789
- By:
- Publication type:
- Article
14
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 633, doi. 10.1038/nrd3800
- By:
- Publication type:
- Article
15
Overtaking the DILI Model-T.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 585, doi. 10.1038/nrd3818
- By:
- Publication type:
- Article
16
Obesity and diabetes: Adenosine pathway increases ?-cell regeneration.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 602, doi. 10.1038/nrd3815
- By:
- Publication type:
- Article
17
Cancer: PD1 makes waves in anticancer immunotherapy.
- Published in:
- 2012
- By:
- Publication type:
- journal article
18
Pasireotide.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 597, doi. 10.1038/nrd3788
- By:
- Publication type:
- Article
19
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 581, doi. 10.1038/nrd3817
- Publication type:
- Article
20
PDUFA V goes back to basics.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 586, doi. 10.1038/nrd3819
- By:
- Publication type:
- Article
21
Anticancer drugs: Antitumour potential of catalytic DNA.
- Published in:
- 2012
- By:
- Publication type:
- journal article
22
Deal watch: Roche deal targets glutamate in neurodevelopmental disorders.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 590, doi. 10.1038/nrd3808
- By:
- Publication type:
- Article
23
Revisiting lab-on-a-chip technology for drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 620, doi. 10.1038/nrd3799
- By:
- Publication type:
- Article
24
Trial watch: Novel antimicrobial fights TB resistance.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 590, doi. 10.1038/nrd3809
- By:
- Publication type:
- Article